Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
BMC Medicine
|
November 13, 2019
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
Peter Hanlon, Laurie Hannigan, Jesus Rodriguez-Perez, et al.
Age and Ageing
|
April 29, 2021
Impact of COVID-19 on care-home mortality and life expectancy in Scotland
Jennifer K Burton, Martin Reid, Ciara Gribben, et al.
Wellcome Open Research
|
August 5, 2022
Self-management interventions for Type 2 Diabetes: systematic review protocol focusing on patient workload and capacity support
Peter Hanlon, Iona Bryson, Holly Morrison, et al.
BMC Medicine
|
October 28, 2022
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
Peter Hanlon, Elaine Butterly, Anoop S V Shah, et al.
British Journal of Cancer
|
October 25, 2023
Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role?
Bhautesh Dinesh Jani, Michael K Sullivan, Peter Hanlon, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 28, 2025
Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort
William Berthon, Stuart J McGurnaghan, Luke A K Blackbourn, et al.
BMC Medicine
|
November 19, 2021
Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings
Michael K Sullivan, Bhautesh Dinesh Jani, Alex McConnachie, et al.
BMC Medicine
|
November 2, 2022
The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
Michael K Sullivan, Juan-Jesus Carrero, Bhautesh Dinesh Jani, et al.
BMJ Medicine
|
March 20, 2023
Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials
Jennifer S Lees, Peter Hanlon, Elaine W Butterly, et al.
BMJ Medicine
|
May 13, 2024
Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data
Jennifer Lees, Jamie Crowther, Peter Hanlon, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
BMC Medicine
|
November 13, 2019
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
Peter Hanlon, Laurie Hannigan, Jesus Rodriguez-Perez, et al.
Age and Ageing
|
April 29, 2021
Impact of COVID-19 on care-home mortality and life expectancy in Scotland
Jennifer K Burton, Martin Reid, Ciara Gribben, et al.
Wellcome Open Research
|
August 5, 2022
Self-management interventions for Type 2 Diabetes: systematic review protocol focusing on patient workload and capacity support
Peter Hanlon, Iona Bryson, Holly Morrison, et al.
BMC Medicine
|
October 28, 2022
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
Peter Hanlon, Elaine Butterly, Anoop S V Shah, et al.
British Journal of Cancer
|
October 25, 2023
Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role?
Bhautesh Dinesh Jani, Michael K Sullivan, Peter Hanlon, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 28, 2025
Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort
William Berthon, Stuart J McGurnaghan, Luke A K Blackbourn, et al.
BMC Medicine
|
November 19, 2021
Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings
Michael K Sullivan, Bhautesh Dinesh Jani, Alex McConnachie, et al.
BMC Medicine
|
November 2, 2022
The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
Michael K Sullivan, Juan-Jesus Carrero, Bhautesh Dinesh Jani, et al.
BMJ Medicine
|
March 20, 2023
Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials
Jennifer S Lees, Peter Hanlon, Elaine W Butterly, et al.
BMJ Medicine
|
May 13, 2024
Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data
Jennifer Lees, Jamie Crowther, Peter Hanlon, et al.
Page
of 9